Ruiyuan Biotech
睿源生物
Ruiyuan Biotech
Biotech/Healthcare
Ruiyuan Bio focuses on key scientific questions surrounding mesenchymal stem cells, such as their 'unclear in vivo fate and unknown mechanism of action.' The company seeks to break through the technical bottleneck of translating stem cells from clinical medical technology into drugs through…
Latest round: Series A Extension (2025)
Source: ChinaBulls — chinabulls.com
Last updated 2025-02-01
Funding history
Request access to view this section.
Investors
Request access to view this section.
HQ & website
Request access to view this section.
Tags
Request access to view this section.